This pharma CEO is in the hot seat over EpiPen price hikes -- and her dad is Sen. Joe Manchin
Heather Bresch, CEO of Mylan, in an interview with IDA Ireland (Screenshot)

Drug company CEO Heather Bresch affectionately describes the humble EpiPen as her "baby," a once-middling product that she turned into a blockbuster. With aggressive advertising - and even more aggressive price hikes - Bresch has fostered the EpiPen into a bestseller that brings in more than $1 billion a year in revenue for Mylan Pharmaceuticals. But…